FDA loosens restrictions on using patient-level RWD in medical device submissions
Regulatory NewsJoanne S. Eglovitch
Approval/marketing authorizationClinical TrialsEmergency use authorization (EUA)Medical DevicesRegulatory Intelligence/PolicyRWE/RWDUnited StatesUS Food and Drug Administration (FDA)